Skip to main content

Table 1 AD case demographics and neuropathological characteristics for transcriptomics

From: APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain

 APOEAgeSexBraak stage
APOE2 carriers2/393F3
2/392F6
2/392F3
2/390F2
2/391F5
2/396M5
2/367M6
2/394M3
Age ± SD (years) 89.38 ± 9.2  
PMI (range; mean) hours 1.4-3.3; 2.48  
APOE3/33/380F6
3/387F6
3/381F6
3/391F6
3/389F6
3/380F6
3/380F6
3/386M6
3/385M6
3/383M6
3/381M6
3/392M6
Age ± SD (years) 84.5 ± 4.4  
PMI (range; mean) hours 2-9; 4.08  
APOE4 carriers3/483F6
3/480F6
3/489F6
3/488F6
3/484F6
3/489F6
3/490F6
3/487F6
3/488M6
3/479M6
3/476M6
3/482M6
3/484M6
3/491M6
3/480M6
3/479M6
4/479F6
4/480F6
4/482M6
4/482M6
4/484M6
4/484M6
Age ± SD (years) 83.6 ± 4.2  
PMI (range; mean) hours 1-15; 4035